Related Experiment Video

Updated: Jun 10, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K

Prospects and challenges of neoantigen applications in oncology

Ranran Shi1, Ling Ran1, Yuan Tian1

  • 1Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China; Henan Province Engineering & Technology Research Center of Foods for Special Medical Purpose, Luohe Medical College, Luohe 462000, China.

International Immunopharmacology
|October 15, 2024
PubMed

Insights

Neoantigens, unique peptides from tumor mutations, offer a promising path for personalized cancer immunotherapy. Research explores their potential and challenges in vaccine and T cell therapies for revolutionizing cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Neoantigens are tumor-specific peptides arising from mutations.
  • They are key targets for personalized cancer immunotherapy.
  • They offer potential for highly specific and effective cancer treatments.

Purpose of the Study:

  • To explore the prospects and challenges of neoantigen application in oncology.
  • To review advances in neoantigen identification and therapeutic development.
  • To discuss obstacles hindering neoantigen-based cancer therapies.

Main Methods:

  • Review of current research and clinical trials on neoantigens.
  • Analysis of neoantigen identification techniques.
  • Examination of vaccine development and adoptive T cell therapy strategies.

Main Results:

  • Neoantigens show promise for overcoming limitations of conventional cancer therapies.
  • Advances in identification and therapeutic strategies are emerging.
  • Significant challenges remain, including neoantigen heterogeneity and tumor microenvironment interactions.

Conclusions:

  • Neoantigens hold revolutionary potential for cancer treatment.
  • Overcoming challenges in prediction and delivery is crucial for clinical success.
  • Further research is needed to fully realize the potential of neoantigen-based immunotherapies.
Keywords:
NeoantigenPersonalized therapyRegulatory challengesTumor heterogeneityTumor immunotherapy

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K